ShareValue scores for ZYBT: Valuation 53, Quality 70, Growth 50, Health 51.

Zhengye Biotechnology Holding Limited Ordinary Shares logo

ZYBT
NASDAQ

Zhengye Biotechnology Holding Limited Ordinary Shares

$2.09(-11.44%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

7% to 16%
Valuation
53
Fair Value
Price vs Value
Quality
70
Moderate
Business Strength
Growth
50
Moderate
Revenue & Earnings
Health
51
Moderate
Financial Stability
Momentum
10
Bearish
Price Trend

Company Details

About

Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in the People's Republic of China. The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs, as well as monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine. It also develops vaccines for household animals, including rabies vaccine and Strain Flury LEP for dogs. In addition, the company exports its products to Vietnam, Pakistan, and Egypt. It serves direct-end customers, including livestock farmers and local governments; and domestic distributors and exporting distributors. The company was incorporated in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026